Hypertension is a major risk factor for heart failure, stroke, and kidney disease. Even small, but persistent increases in arterial blood pressure lead to pathological remodeling of the vessels and heart, and are associated with reduced life expectancy. Vascular smooth muscle cell (VSMC) contractility and remodeling are two critical Ca2+-dependent mechanisms that contribute to hypertension. The highly Ca2+-selective plasma membrane (PM) Orai channel proteins which are controlled by the universal endoplasmic reticulum (ER) Ca2+ sensor protein, STIM1 are upregulated in VSMC during hypertension. Our published and preliminary data demonstrate that Store-independent Orai channels (SICs) are encoded by heterohexamers of two exclusively mammalian proteins: Orai3 and the long variant of Orai1, Orai1?. We demonstrated that Orai1?/3-SIC is required for VSMC migration and for neointima formation after vascular injury, yet does not play a role in proliferation. Orai1?/3-SIC expression and activity are specifically upregulated in VSMC during hypertension. Our major objective is to determine the role and regulation of this unique Orai1?/3-SIC in VSMC dysfunction during hypertension. We hypothesize that Orai1?/3-SIC generate Ca2+ signals in VSMC that control unique downstream pathways to mediate contractility and/or remodeling in hypertension. We propose three aims. 1: To determine the specific heteromeric assembly and regulation of native Orai1?/3-SIC in VSMC. The oligomeric state and mode of regulation by Ca2+ of native Orai1?/3-SIC will be investigated using novel fluorescently-labeled Orai isoforms expressed at endogenous levels in Cas9/CRISPR Orai-knockout VSMC. These studies will combine high-resolution FRET and confocal imaging and biophysical channel measurements using mutant and concatenated Orai1?/3 hexameric channel constructs. 2: To elucidate the downstream SIC-specific signaling pathways and determine the spatial and temporal Orai1?/3-generated Ca2+ microdomains in migrating VSMC. Having established the role of Orai1?/3-SIC in migration, we will utilize novel light-activated Orai-derived single-molecule probes containing tethered genetically-encoded Ca2+ indicators, to define Orai1?/3-generated Ca2+ signals, their PM localization and the immediate signaling pathways and long-term transcriptional regulation in migrating VSMC. 3: To determine the in vivo role of Orai1? and Orai3 in vascular dysfunction, contractility and remodeling in hypertension. Using Orai1?SMC-/- and Orai3SMC-/- mice expressing ratiometric GCamp5/mCherry Ca2+ indicator exclusively in SMC, we will determine the specific role of VSMC Orai1?/3-SIC-mediated Ca2+ signals in hypertension and associated vascular dysfunction. This proposal will use mechanistic and translational approaches to enhance our understanding of VSMC physiology and pathophysiology, and establish VSMC Orai1? and Orai3 as novel therapeutic targets in hypertension and other vascular diseases.
Chronic hypertension is a major risk factor for heart failure, stroke, aneurysm, and kidney disease. Hypertension is associated with pathological remodeling of the vessels and heart, and with a short life expectancy. Research from this proposal will generate new mechanistic insights into the molecular mechanisms of vascular smooth muscle cell (VSMC) remodeling and contractility during hypertension and establish Orai3 and Orai1? channels as novel targets for drug therapies aimed at preventing VSMC dysfunction during hypertension and other vascular diseases. The exclusively mammalian proteins Orai3 and Orai1? play a crucial role in VSMC dysfunction, yet they do not participate in canonical Ca2+ entry pathways which are required for development of immune, secretory and muscle tissues. This fact makes Orai3 and Orai1? molecules highly suitable for effective drug targeting of vascular disease generating little or no side effects.
| Pierro, Cristina; Zhang, Xuexin; Kankeu, Cynthia et al. (2018) Oncogenic KRAS suppresses store-operated Ca2+ entry and ICRAC through ERK pathway-dependent remodelling of STIM expression in colorectal cancer cell lines. Cell Calcium 72:70-80 |
| Pathak, Trayambak; Trebak, Mohamed (2018) Mitochondrial Ca2+ signaling. Pharmacol Ther 192:112-123 |
| Zhou, Yandong; Nwokonko, Robert M; Cai, Xiangyu et al. (2018) Cross-linking of Orai1 channels by STIM proteins. Proc Natl Acad Sci U S A 115:E3398-E3407 |
| Cai, Xiangyu; Nwokonko, Robert M; Loktionova, Natalia A et al. (2018) Pore properties of Orai1 calcium channel dimers and their activation by the STIM1 ER calcium sensor. J Biol Chem 293:12962-12974 |
| Zhang, Xuexin; Spinelli, Amy M; Zhang, Wei et al. (2018) Study of the Endogenous CRAC Channel Using shRNA-Mediated Gene Silencing. Methods Mol Biol 1843:137-145 |
| Verkhratsky, Alexei; Trebak, Mohamed; Perocchi, Fabiana et al. (2018) Crosslink between calcium and sodium signalling. Exp Physiol 103:157-169 |
| Johnson, Martin; Trebak, Mohamed (2018) Slow Traffic Makes for Bad Circulation. Hypertension 72:585-587 |
| Hanes, Cheryl M; D'Amico, Anna E; Ueyama, Takehiko et al. (2017) Golgi-Associated Protein Kinase C-? Is Delivered to Phagocytic Cups: Role of Phosphatidylinositol 4-Phosphate. J Immunol 199:271-277 |
| Trebak, Mohamed; Putney Jr, James W (2017) ORAI Calcium Channels. Physiology (Bethesda) 32:332-342 |
| Tanwar, Jyoti; Trebak, Mohamed; Motiani, Rajender K (2017) Cardiovascular and Hemostatic Disorders: Role of STIM and Orai Proteins in Vascular Disorders. Adv Exp Med Biol 993:425-452 |
Showing the most recent 10 out of 67 publications
